Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-025901

Options or other derivatives

  • Director acquired 164,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kirsch Arthur S Director 2025-02-20 Grant or award · Stock Option (Right to Buy) +164,800 164,800 D
Loading xslF345X05/ownership.xml…